BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 30511454)

  • 1. Early growth response-1 regulates acetylcholinesterase and its relation with the course of Alzheimer's disease.
    Hu YT; Chen XL; Huang SH; Zhu QB; Yu SY; Shen Y; Sluiter A; Verhaagen J; Zhao J; Swaab D; Bao AM
    Brain Pathol; 2019 Jul; 29(4):502-512. PubMed ID: 30511454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-132 and early growth response-1 in nucleus basalis of Meynert during the course of Alzheimer's disease.
    Zhu QB; Unmehopa U; Bossers K; Hu YT; Verwer R; Balesar R; Zhao J; Bao AM; Swaab D
    Brain; 2016 Mar; 139(Pt 3):908-21. PubMed ID: 26792551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex differences in hippocampal β-amyloid accumulation in the triple-transgenic mouse model of Alzheimer's disease and the potential role of local estrogens.
    Hu YT; Chen XL; Zhang YN; McGurran H; Stormmesand J; Breeuwsma N; Sluiter A; Zhao J; Swaab D; Bao AM
    Front Neurosci; 2023; 17():1117584. PubMed ID: 36968493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased Expression of Readthrough Acetylcholinesterase Variants in the Brains of Alzheimer's Disease Patients.
    Campanari ML; Navarrete F; Ginsberg SD; Manzanares J; Sáez-Valero J; García-Ayllón MS
    J Alzheimers Dis; 2016 May; 53(3):831-41. PubMed ID: 27258420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acetylcholinesterase is increased in the brains of transgenic mice expressing the C-terminal fragment (CT100) of the beta-amyloid protein precursor of Alzheimer's disease.
    Sberna G; Sáez-Valero J; Li QX; Czech C; Beyreuther K; Masters CL; McLean CA; Small DH
    J Neurochem; 1998 Aug; 71(2):723-31. PubMed ID: 9681463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of peripheral luteinizing hormone rescues ovariectomy-associated cognitive deficits in APP/PS1 mice.
    Zhang YN; Chen XL; Guo LY; Jiang PR; Lu H; Pan K; Guo L; Hu YT; Bao AM
    Neurobiol Aging; 2024 Mar; 135():60-69. PubMed ID: 38185053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of huprine X on β-amyloid, synaptophysin and α7 neuronal nicotinic acetylcholine receptors in the brain of 3xTg-AD and APPswe transgenic mice.
    Hedberg MM; Clos MV; Ratia M; Gonzalez D; Lithner CU; Camps P; Muñoz-Torrero D; Badia A; Giménez-Llort L; Nordberg A
    Neurodegener Dis; 2010; 7(6):379-88. PubMed ID: 20689242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early growth response gene 1 (EGR1) regulates heparanase gene transcription in tumor cells.
    de Mestre AM; Rao S; Hornby JR; Soe-Htwe T; Khachigian LM; Hulett MD
    J Biol Chem; 2005 Oct; 280(42):35136-47. PubMed ID: 16093249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in readthrough acetylcholinesterase expression modulate amyloid-beta pathology.
    Berson A; Knobloch M; Hanan M; Diamant S; Sharoni M; Schuppli D; Geyer BC; Ravid R; Mor TS; Nitsch RM; Soreq H
    Brain; 2008 Jan; 131(Pt 1):109-19. PubMed ID: 18056160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional effects of donepezil and rivastigmine on cortical acetylcholinesterase activity in Alzheimer's disease.
    Kaasinen V; Någren K; Järvenpää T; Roivainen A; Yu M; Oikonen V; Kurki T; Rinne JO
    J Clin Psychopharmacol; 2002 Dec; 22(6):615-20. PubMed ID: 12454562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 6-Methyluracil derivatives as acetylcholinesterase inhibitors for treatment of Alzheimer's disease.
    Zueva IV; Semenov VE; Mukhamedyarov MA; Lushchekina SV; Kharlamova AD; Petukhova EO; Mikhailov AS; Podyachev SN; Saifina LF; Petrov KA; Minnekhanova OA; Zobov VV; Nikolsky EE; Masson P; Reznik VS
    Int J Risk Saf Med; 2015; 27 Suppl 1():S69-71. PubMed ID: 26639718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Egr1 regulates lithium-induced transcription of the Period 2 (PER2) gene.
    Kim SH; Yu HS; Park HG; Ahn YM; Kim YS; Lee YH; Ha K; Shin SY
    Biochim Biophys Acta; 2013 Dec; 1832(12):1969-79. PubMed ID: 23816566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transgenic autoinhibition of p21-activated kinase exacerbates synaptic impairments and fronto-dependent behavioral deficits in an animal model of Alzheimer's disease.
    Bories C; Arsenault D; Lemire M; Tremblay C; De Koninck Y; Calon F
    Aging (Albany NY); 2017 May; 9(5):1386-1403. PubMed ID: 28522792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered glycosylation of acetylcholinesterase in APP (SW) Tg2576 transgenic mice occurs prior to amyloid plaque deposition.
    Fodero LR; Sáez-Valero J; McLean CA; Martins RN; Beyreuther K; Masters CL; Robertson TA; Small DH
    J Neurochem; 2002 May; 81(3):441-8. PubMed ID: 12065653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide approaches reveal EGR1-controlled regulatory networks associated with neurodegeneration.
    Koldamova R; Schug J; Lefterova M; Cronican AA; Fitz NF; Davenport FA; Carter A; Castranio EL; Lefterov I
    Neurobiol Dis; 2014 Mar; 63():107-14. PubMed ID: 24269917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal circadian locomotor rhythms and Per gene expression in six-month-old triple transgenic mice model of Alzheimer's disease.
    Wu M; Zhou F; Cao X; Yang J; Bai Y; Yan X; Cao J; Qi J
    Neurosci Lett; 2018 May; 676():13-18. PubMed ID: 29626648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laminar organization of cholinergic circuits in human frontal cortex in Alzheimer's disease and aging.
    DeKosky ST; Scheff SW; Markesbery WR
    Neurology; 1985 Oct; 35(10):1425-31. PubMed ID: 4033925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional Remodeling in Primary Hippocampal Astrocytes from an Alzheimer's Disease Mouse Model.
    Ruffinatti F; Tapella L; Gregnanin I; Stevano A; Chiorino G; Canonico PL; Distasi C; Genazzani AA; Lim D
    Curr Alzheimer Res; 2018; 15(11):986-1004. PubMed ID: 29895250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional regulation of T-type calcium channel CaV3.2: bi-directionality by early growth response 1 (Egr1) and repressor element 1 (RE-1) protein-silencing transcription factor (REST).
    van Loo KM; Schaub C; Pernhorst K; Yaari Y; Beck H; Schoch S; Becker AJ
    J Biol Chem; 2012 May; 287(19):15489-501. PubMed ID: 22431737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of cholinergic markers in Alzheimer's disease and in a model of cholinergic deficit.
    Gil-Bea FJ; García-Alloza M; Domínguez J; Marcos B; Ramírez MJ
    Neurosci Lett; 2005 Feb; 375(1):37-41. PubMed ID: 15664119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.